[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Catheters Global Market – Forecast To 2022

March 2016 | 322 pages | ID: CAB18A3794DEN
IQ4I Research & Consultancy Pvt. Ltd.

US$ 4,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Catheter is a tubular medical device introduced into different body canals, vessels, passage ways and cavities for diagnostic or therapeutic purposes. These catheters are made of different types of polymers and inert materials, and are coated with antimicrobial and special substances to avoid infections and other complications. The catheters are used in various medical fields such as neurovascular, cardiovascular, urology and other specialty segments like nephrology, gynecology, and gastroenterology.

Catheters market is segmented on the basis of product type, materials, end-users and geography. Product type is further segmented into cardiovascular, neurovascular, urinary, intravenous, specialities. The cardiovascular segment is further subsegmented into electrophysiology catheters, balloon catheters, guiding catheters, pulmonary artery catheters, and intravascular ultrasound catheters. Neurovascular catheters are further classified into micro catheters, neuro thrombectomy catheters and neuro embolization catheters. Urinary catheters are segmented into intermittent (temporary) catheters, foley (indwelling) catheters and male external catheters. Intravenous catheters include peripheral catheters, central venous catheters, similarly specialty catheters are segmented into wound/surgical drain catheters, oximetry catheters, thermodilution catheters, gastroenterology catheters, gynaecology catheters and dialysis Catheters.

Based on materials the catheters market is segmented into silicone, polyurethane, polyethylene, teflon/ PTFE and others. End-users are segmented into hospitals, diagnostic laboratories, academic and research laboratories, ambulatory surgical centers, home healthcare providers.

Among the catheters products, the cardiovascular catheter market dominates the products market by occupying a largest share of 33.7%. At the same time, specialty catheters market is the fastest growing segment with a high single digit CAGR from 2015 to 2022. In materials, the silicone is the largest segment with 28.8% share and polyethylene are the fastest growing segment with a high single digit CAGR from 2015 to 2022. In end- users, hospitals are the largest segment as well as fastest growing segment from 2015 to 2022. Geographically, North America is the largest market, followed by Europe and Asia. The APAC region is the fastest growing region with a double digit CAGR from 2015 to 2022 presenting an array of opportunities for growth and is likely to get attention of new investors in the catheters market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.

The catheters market is expected to grow steadily at a CAGR of XX% during 2015 to 2022. Increased life expectancy and combined with rise in aging population, growing prevalence of cardiovascular diseases, diabetes and urinary diseases, growing healthcare expenditures in developing countries and trend towards the use of single use catheters and self catheterization are the factors driving the market growth. Adoption of minimally invasive procedures, growing advent of technological advancements pertaining to catheter materials that prevent biofilm formation and developing nations like India and China catheters market are expected to offer potential opportunities.

Similarly various factors like increasing rate of Catheter Assisted-Urinary Tract Infection (CA-UTI) associated with healthcare acquired infections, high cost involved in cardiac and neurological procedures and lack of experienced and skilled professionals limit the growth of catheters global market. The threats for the catheters market include increase in pricing pressure on market players and stringent regulatory bodies.

The catheters global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the catheters market are Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), B.Braun Melsungen AG (Germany), Beckton Dickinson (U.S.), C.R.Bard (U.S.), ColoPlast (Denmark), Angio Dynamics (U.S.), St. Jude Medical (U.S.) and Philips (Netherlands).

The report provides an in depth market analysis of the above mentioned segments across the following regions:
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)
1 EXECUTIVE SUMMARY

2 INTRODUCTION

2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
  2.5.1 MARKET SIZE ESTIMATION
  2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
  2.5.3 SECONDARY SOURCES
  2.5.4 PRIMARY SOURCES
  2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
  2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
  2.5.7 ASSUMPTIONS

3 MARKET ANALYSIS

3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
  3.3.1 DRIVERS & OPPORTUNITIES
    3.3.1.1 Increasing life expectancy combined with rise in aging population
    3.3.1.2 Growing prevalence of cardiovascular diseases, diabetes and urinary diseases
    3.3.1.3 Growing healthcare budgetary allocation in developing countries
    3.3.1.4 Trends towards single use catheters and self catheterization
    3.3.1.5 Emerging economies like india and china catheters market are expected to offer potential opportunities
    3.3.1.6 Adoption of minimally invasive procedures
    3.3.1.7 Technological advancements pertaining to catheters materials that prevent biofilm formation
  3.3.2 RESTRAINTS & THREATS
    3.3.2.1 Increasing incidences of acquired infections due to biofilm formation during use of long term indwelling catheters
    3.3.2.2 High cost involved in cardiac and neurological procedures
    3.3.2.3 Lack of experienced and skilled professional to handle the catheters insertion procedure
    3.3.2.4 Increase in pricing pressure on market players
    3.3.2.5 Stringent regulatory bodies
3.4 REGULATORY AFFAIRS
  3.4.1 U.S.
  3.4.2 EUROPE
  3.4.3 CHINA
  3.4.4 INDIA
  3.4.5 JAPAN
3.5 REIMBURSEMENT SCENARIO
  3.5.1 REIMBURSEMENT Table
3.6 TECHNOLOGICAL ADVANCEMENTS AND UPCOMING TECHNOLOGIES & PRODUCT LAUNCHES
  3.6.1 CATHETER BASED IMAGING DEVICES (IMAGING CATHETERS)
  3.6.2 CATH LAB
  3.6.3 ROBOTIC CATHETERS
  3.6.4 3D PRINTED & CUSTOM CATHETERS
  3.6.5 SPRAY CATHETERS
  3.6.6 LASER FIBER CATHETERS
  3.6.7 SINGLE USE REPROCESSED CATHETERS
  3.6.8 TECHNOLOGIES UNDER CLINICAL TRIAL
  3.6.9 RECENT AND UPCOMING PRODUCT LAUNCHES
3.7 COATINGS FOR CATHETERS
3.8 PORTER’S FIVE FORCE ANALYSIS
  3.8.1 THREAT OF NEW ENTRANTS
  3.8.2 THREAT OF SUBSTITUTES
  3.8.3 RIVALRY AMONG EXISTING COMPETITORS
  3.8.4 BARGAINING POWER OF SUPPLIERS
  3.8.5 BARGAINING POWER OF BUYERS
3.9 SUPPLY CHAIN ANALYSIS
3.10 PATENT ANALYSIS
3.11 MARKET SHARE ANALYSIS

4 CATHETERS GLOBAL MARKET, BY PRODUCT TYPE

4.1 INTRODUCTION
4.2 CARDIAC CATHETERS
  4.2.1 BALLOON CATHETERS
    4.2.1.1 Angiography balloon catheters
    4.2.1.2 Angioplasty balloon catheters
      4.2.1.2.1 Percutaneous transluminal coronary angioplasty (PTCA) balloon catheters
      4.2.1.2.2 Percutaneous transluminal angioplasty (PTA) balloon catheters
  4.2.2 ELECTROPHYSIOLOGY CATHETERS
    4.2.2.1 Diagnostic electrophysiology catheters
    4.2.2.2 Ablation electrophysiology catheters
  4.2.3 GUIDING CATHETERS
  4.2.4 PULMONARY ARTERY CATHETERS
  4.2.5 INTRAVASCULAR ULTRASOUND CATHETERS
4.3 URINARY CATHETERS
  4.3.1 INTERMITTENT (TEMPORARY OR SHORT-TERM) CATHETERS
  4.3.2 FOLEY (INDWELLING OR SUPRAPUBIC) CATHETERS
  4.3.3 MALE EXTERNAL CATHETERS (CONDOM CATHETERS)
4.4 NEUROVASCULAR CATHETERS
  4.4.1 MICRO CATHETERS
  4.4.2 NEURO THROMBECTOMY CATHETERS
  4.4.3 NEURO EMBOLIZATION CATHETERS
4.5 INTRAVENOUS CATHETERS
  4.5.1 PERIPHERAL CATHETERS
    4.5.1.1 Midline peripheral catheters
  4.5.2 CENTRAL VENOUS CATHETERS
    4.5.2.1 Peripherally inserted central catheters (PICC)
    4.5.2.2 Central venous catheter
    4.5.2.3 Non-tunneled external catheter
    4.5.2.4 Tunneled external catheter
4.6 SPECIALTY CATHETER
  4.6.1 WOUND/SURGICAL DRAIN CATHETERS
  4.6.2 OXIMETRY CATHETERS
  4.6.3 THERMODILUTION CATHETERS
  4.6.4 DIALYSIS CATHETERS
  4.6.5 GYNAECOLOGY CATHETERS
  4.6.6 GASTROENTEROLOGY CATHETER

5 CATHETERS GLOBAL MARKET, BY MATERIALS

5.1 INTRODUCTION
5.2 CATHETERS MATERIAL COMPARISON
5.3 SILICONE CATHETERS
5.4 POLYURETHANE CATHETERS
5.5 POLYETHYLENE CATHETERS
5.6 TEFLON/PTFE CATHETERS
5.7 OTHERS (NITINOL, NYLON) CATHETERS

6 CATHETERS GLOBAL MARKET, BY END-USERS

6.1 INTRODUCTION
6.2 HOSPITALS
6.3 AMBULATORY SURGICAL CENTERS
6.4 DIAGNOSTIC LABORATORIES
6.5 ACADEMIC RESEARCH LABORATORIES
6.6 HOME HEALTHCARE PROVIDERS

7 REGIONAL ANALYSIS

7.1 INTRODUCTION
7.2 NORTH AMERICA
7.3 EUROPE
7.4 ASIA PACIFIC
  7.4.1 INDIA
  7.4.2 CHINA
7.5 REST OF THE WORLD

8 COMPANY DEVELOPMENTS

8.1 INTRODUCTION
8.2 APPROVALS
8.3 ACQUISITIONS & COLLABORATIONS
8.4 NEW PRODUCT LAUNCHES
8.5 AGREEMENTS & EXPANSION

9 COMPANY PROFILES

9.1 ABBOTT LABORATORIES
  9.1.1 OVERVIEW
  9.1.2 FINANCIALS
  9.1.3 PRODUCT PORTFOLIO
  9.1.4 KEY DEVELOPMENTS
  9.1.5 BUSINESS STRATEGY
  9.1.6 SWOT ANALYSIS
9.2 ANGIODYNAMICS INC.
  9.2.1 OVERVIEW
  9.2.2 FINANCIALS
  9.2.3 PRODUCT PORTFOLIO
  9.2.4 KEY DEVELOPMENTS
  9.2.5 BUSINESS STRATEGY
  9.2.6 SWOT ANALYSIS
9.3 B. BRAUN MELSUNGEN AG
  9.3.1 OVERVIEW
  9.3.2 FINANCIALS
  9.3.3 PRODUCT PORTFOLIO
  9.3.4 KEY DEVELOPMENTS
  9.3.5 BUSINESS STRATEGY
  9.3.6 SWOT ANALYSIS
9.4 BECTON, DICKINSON AND COMPANY
  9.4.1 OVERVIEW
  9.4.2 FINANCIALS
  9.4.3 PRODUCT PORTFOLIO
  9.4.4 KEY DEVELOPMENTS
  9.4.5 BUSINESS STRATEGY
  9.4.6 SWOT ANALYSIS
9.5 BOSTON SCIENTIFIC CORPORATION
  9.5.1 OVERVIEW
  9.5.2 FINANCIALS
  9.5.3 PRODUCT PORTFOLIO
  9.5.4 KEY DEVELOPMENTS
  9.5.5 BUSINESS STRATEGY
  9.5.6 SWOT ANALYSIS
9.6 C.R.BARD, INC.
  9.6.1 OVERVIEW
  9.6.2 FINANCIALS
  9.6.3 PRODUCT PORTFOLIO
  9.6.4 KEY DEVELOPMENTS
  9.6.5 BUSINESS STRATEGY
  9.6.6 SWOT ANALYSIS
9.7 COLOPLAST
  9.7.1 OVERVIEW
  9.7.2 FINANCIALS
  9.7.3 PRODUCT PORTFOLIO
  9.7.4 KEY DEVELOPMENTS
  9.7.5 BUSINESS STRATEGY
  9.7.6 SWOT ANALYSIS
9.8 JOHNSON & JOHNSON
  9.8.1 OVERVIEW
  9.8.2 FINANCIALS
  9.8.3 PRODUCT PORTFOLIO
  9.8.4 KEY DEVELOPMENTS
  9.8.5 BUSINESS STRATEGY
  9.8.6 SWOT ANALYSIS
9.9 PHILIPS HEALTHCARE
  9.9.1 OVERVIEW
  9.9.2 FINANCIALS
  9.9.3 PRODUCT PORTFOLIO
  9.9.4 KEY DEVELOPMENTS
  9.9.5 BUSINESS STRATEGY
  9.9.6 SWOT ANALYSIS
9.10 ST JUDE MEDICAL, INC
  9.10.1 OVERVIEW
  9.10.2 FINANCIALS
  9.10.3 PRODUCT PORTFOLIO
  9.10.4 KEY DEVELOPMENTS
  9.10.5 BUSINESS STRATEGY
  9.10.6 SWOT ANALYSIS
9.11 TELEFLEX INCORPORATED
  9.11.1 OVERVIEW
  9.11.2 FINANCIALS
  9.11.3 PRODUCT PORTFOLIO
  9.11.4 KEY DEVELOPMENTS
  9.11.5 BUSINESS STRATEGY
  9.11.6 SWOT ANALYSIS

LIST OF TABLES

Table 1 CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 2 CATHETERS GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2014-2022) ($MN)
Table 3 CARDIOVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 4 CARDIOVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 5 BALLOON CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 6 ANGIOGRAPHY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 7 ANGIOPLASTY CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 8 ANGIOPLASTY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 9 PTCA (PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY) BALLOON CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 10 PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY) BALLOON CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 11 ELECTROPHYSIOLOGY CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 12 ELECTROPHYSIOLOGY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 13 DIAGNOSTIC ELECTROPHYSIOLOGY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 14 ABLATION ELECTROPHYSIOLOGY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 15 GUIDING CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 16 PULMONARY ARTERY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 17 INTRAVASCULAR ULTRASOUND CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 18 URINARY CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 19 URINARY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 20 INTERMITTENT (TEMPERORY) CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 21 FOLEY (INDWELLING) CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 22 MALE EXTERNAL CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 23 NEUROVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 24 NEUROVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 25 MICRO CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 26 NEURO THROMBECTOMY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 27 NEURO EMBOLIZATION CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 28 INTRAVENOUS CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 29 INTRAVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 30 PERIPHERAL CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 31 CENTRAL VENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 32 CENTRAL VENOUS CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 33 PICC GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 34 CVC GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 35 NON-TUNNELED EXTERNAL CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 36 TUNNELED EXTERNAL CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 37 SPECIALTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 38 SPECIALTY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 39 WOUND/SURGICAL DRAIN CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 40 OXIMETRY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 41 THERMODILUTION CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 42 DIALYSIS CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 43 GYNAECOLOGY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 44 GASTROENTEROLOGY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 45 CATHETERS GLOBAL MARKET REVENUE, BY MATERIALS, (2014-2022) ($MN)
Table 46 SILICONE CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 47 POLYURETHANE CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 48 POLYETHYLENE CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 49 TEFLON/PTFE CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 50 OTHER CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 51 CATHETERS GLOBAL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 52 HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 53 AMBULATORY SURGICAL CENTRES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 54 DIAGNOSTIC LABORATORIES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 55 ACADEMIC & RESEARCH LABORATORIES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 56 HOME HEALTHCARE PROVIDERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 57 NORTH AMERICAN CATHETERS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 58 NORTH AMERICAN CARDIOVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 59 NORTH AMERICAN ELECTROPHYSIOLOGY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 60 NORTH AMERIAN BALLOON CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 61 NORTH AMERICAN ANGIOPLASTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 62 NORTH AMERICAN NEUROVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 63 NORTH AMERICAN URINARY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 64 NORTH AMERICAN INTRAVENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 65 NORTH AMERICAN CENTRAL VENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 66 NORTH AMERICAN SPECIALTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 67 NORTH AMERICAN CATHETERS MARKET REVENUE, BY MATERIAL, (2014-2022) ($MN)
Table 68 NORTH AMERICAN CATHETERS MARKET REVENUE, BY END-USER, (2014-2022) ($MN)
Table 69 EUROPEAN CATHETERS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 70 EUROPEAN CARDIOVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 71 EUROPEAN ELECTROPHYSIOLOGY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 72 EUROPEAN BALLOON CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 73 EUROPEAN ANGIOPLASTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 74 EUROPEAN NEUROVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 75 EUROPEAN URINARY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 76 EUROPEAN INTRAVENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 77 EUROPEAN CENTRAL VENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 78 EUROPEAN SPECIALTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 79 EUROPEAN CATHETERS MARKET REVENUE, BY MATERIAL, (2014-2022) ($MN)
Table 80 EUROPEAN CATHETERS MARKET REVENUE, BY END-USER, (2014-2022) ($MN)
Table 81 ASIA PACIFIC CATHETERS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 82 ASIA PACIFIC CARDIOVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 83 ASIA PACIFIC ELECTROPHYSIOLOGY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 84 ASIA PACIFIC BALLOON CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 85 ASIA PACIFIC ANGIOPLASTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 86 ASIA PACIFIC NEUROVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 87 ASIA PACIFIC URINARY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 88 ASIA PACIFIC INTRAVENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 89 ASIA PACIFIC CENTRAL VENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 90 ASIA PACIFIC SPECIALTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 91 ASIA PACIFIC CATHETERS MARKET REVENUE, BY MATERIAL, (2014-2022) ($MN)
Table 92 ASIA PACIFIC CATHETERS MARKET REVENUE, BY END-USER, (2014-2022) ($MN)
Table 93 ROW CATHETERS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 94 ROW CARDIOVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 95 ROW ELECTROPHYSIOLOGY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 96 ROW BALLOON CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 97 ROW ANGIOPLASTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 98 ROW NEUROVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 99 ROW URINARY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 100 ROW INTRAVENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 101 ROW CENTRAL VENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 102 ROW SPECIALTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 103 ROW CATHETERS MARKET REVENUE, BY MATERIAL, (2014-2022) ($MN)
Table 104 ROW CATHETERS MARKET REVENUE, BY END-USER, (2014-2022) ($MN)
Table 105 APPROVALS (2013-2015)
Table 106 ACQUISTIONS & COLLABORATIONS (2013-2015)
Table 107 NEW PRODUCT LAUNCHES (2013-2015)
Table 108 AGREEMENTS & EXPANSION (2013-2015)
Table 109 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 110 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 111 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 112 ANGIODYNAMICS INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 113 ANGIODYNAMICS INC.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 114 ANGIODYNAMICS INC.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 115 B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 116 B.BRAUN MELSUNGEN AG: TOTAL REVENUE, BY SEGMENT, (2012-2014) ($MN)
Table 117 B.BRAUN MELSUNGEN AG: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 118 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 119 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 120 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($ MN)
Table 121 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 122 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2013-15) ($MN)
Table 123 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 124 C.R.BARD INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 125 C.R.BARD INC: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 126 COLOPLAST: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 127 COLOPLAST: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 128 COLOPLAST: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 129 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 130 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 131 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 132 PHILIPS N.V.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 133 PHILIPS N.V.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 134 PHILIPS HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 135 ST JUDE MEDICAL: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 136 ST JUDE MEDICAL: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 137 ST.JUDE MEDICAL: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 138 TELEFLEX INCORPORATED.: TOTAL SALES AND R&D EXPENSES, (2013-2015) ($MN)
Table 139 TELEFLEX INCORPORATED: TOTAL SALES, BY SEGMENTS, (2013-2015) ($MN)
Table 140 TELEFLEX INCORPORATED: TOTAL SALES, BY GEOGRAPHY, (2013-2015) ($MN)

LIST OF FIGURES

Figure 1 CATHETERS GLOBAL MARKET REVENUE, BY REGION (2014-2022)
Figure 2 CATHETERS GLOBAL MARKET: RESEARCH APPROACH
Figure 3 CATHETERS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 CATHETERS GLOBAL MARKET: FORECASTING MODEL
Figure 5 CATHETERS GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
Figure 6 CATHETER GLOBAL MARKET: MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 CATHETERS GLOBAL MARKET: PORTER’S ANALYSIS
Figure 9 CATHETERS MARKET:PATENT FILING BY MAJOR PLAYERS (2011-2016)
Figure 10 CATHETERS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015
Figure 11 CATHETERS GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2015 V’S 2022) ($MN)
Figure 12 CARDIOVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 13 URINARY CATHETERS MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 14 NEUROVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 15 INTRAVENOUS CATHETER GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 16 SPECIALTY CATHETER GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 17 CATHETER GLOBAL MARKET REVENUE, BY MATERIAL, (2015 V’S 2022) ($MN)
Figure 18 CATHETER GLOBAL MARKET REVENUE, BY END-USERS, (2015 V’S 2022) ($MN)
Figure 19 CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Figure 20 NORTH AMERICAN CATHETERS MARKET SIZE, BY PRODUCT, MATERIAL, & END-USER OUTLOOK, (2015 V’S 2022) ($MN)
Figure 21 EUROPEAN CATHETERS MARKET SIZE, BY PRODUCTS, MATERIALS & END-USER OUTLOOK, (2015 V’S 2022) ($MN)
Figure 22 ASIA-PACIFIC CATHETERS MARKET SIZE, BY PRODUCT, MATERIAL & END-USER OUTLOOK, (2015 V’S 2022) ($MN)
Figure 23 ROW CATHETERS MARKET SIZE, BY PRODUCT, MATERIAL & END-USER OUTLOOK, (2015 V’S 2022) ($MN)
Figure 24 KEY GROWTH STRATEGIES, (2013-2015)
Figure 25 SWOT: ABBOTT LABORATORIES
Figure 26 SWOT: ANGIODYNAMICS, INC.
Figure 27 SWOT: B.BRAUN MELSUNGEN AG
Figure 28 SWOT: BECTON DICKINSON & COMPANY
Figure 29 SWOT: BOSTON SCIENTIFIC CORPORATION
Figure 30 SWOT: C.R.BARD INC.
Figure 31 SWOT: COLOPLAST
Figure 32 SWOT: JOHNSON & JOHNSON
Figure 33 SWOT: PHILIPS HEALTHCARE
Figure 34 SWOT: ST.JUDE MEDICAL
Figure 35 SWOT: TELEFLEX INCORPORATED


More Publications